Magromag

Nitrofurantoin, the active ingredient in Magromag, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It treats uncomplicated urinary tract infections in adult patients. GNH USA supplies Magromag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin is indicated for infections of the urinary tract and related conditions. - Uncomplicated urinary tract infection: reduces bacterial load and resolves symptoms. - Acute cystitis: provides bacteriostatic/bactericidal activity against common uropathogens. - Recurrent UTI prophylaxis: helps prevent recurrence when used as prescribed.

Adverse reactions may occur with nitrofurantoin therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional expulsion of stomach contents. - Loss of appetite: reduced desire to eat. - Abdominal pain: cramping or discomfort in the stomach area. - Diarrhoea: loose stools occurring during treatment. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute respiratory distress. - Hepatic injury: elevated liver enzymes or hepatitis. - Hemolytic anemia: especially in patients with G6PD deficiency. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Peripheral neuropathy: tingling or numbness in extremities. - Eosinophilic pneumonia: inflammatory lung condition with eosinophil accumulation.

Before prescribing nitrofurantoin, consider the following safety measures. - Renal function: assess creatinine clearance to ensure adequate excretion. - Pregnancy: category B; use only when benefit outweighs potential risk. - Elderly patients: monitor for reduced renal clearance and increased exposure. - G6PD deficiency: avoid due to risk of hemolysis. - Drug interactions: review concomitant medications for potential effects. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Nitrofurantoin may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Antacids containing magnesium or aluminium: reduce nitrofurantoin absorption. - Probenecid: decreases renal excretion, increasing toxicity risk. - Cimetidine: may raise serum nitrofurantoin levels.

Moderate Interactions (Monitor Closely): - Warfarin: nitrofurantoin can enhance anticoagulant effect. - Methenamine: additive urinary‑tract effects may increase irritation. - Fluoroquinolones: overlapping toxicity profiles warrant careful observation.